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Abstract
Glycosylation plays crucial regulatory roles in various biological processes such as development, immunity, and neural
functions. For example, a1,3-fucosylation, the addition of a fucose moiety abundant in Drosophila neural cells, is essential for
neural development, function, and behavior. However, it remains largely unknown how neural-specific a1,3-fucosylation is
regulated. In the present study, we searched for genes involved in the glycosylation of a neural-specific protein using a
Drosophila RNAi library. We obtained 109 genes affecting glycosylation that clustered into nine functional groups. Among
them, members of the RNA regulation group were enriched by a secondary screen that identified genes specifically
regulating a1,3-fucosylation. Further analyses revealed that an RNA–binding protein, second mitotic wave missing (Swm),
upregulates expression of the neural-specific glycosyltransferase FucTA and facilitates its mRNA export from the nucleus.
This first large-scale genetic screen for glycosylation-related genes has revealed novel regulation of fucTA mRNA in neural
cells.
Citation: Yamamoto-Hino M, Kanie Y, Awano W, Aoki-Kinoshita KF, Yano H, et al. (2010) Identification of Genes Required for Neural-Specific Glycosylation Using
Functional Genomics. PLoS Genet 6(12): e1001254. doi:10.1371/journal.pgen.1001254
Editor: Norbert Perrimon, Harvard Medical School, Howard Hughes Medical Institute, United States of America
Received May 3, 2010; Accepted November 19, 2010; Published December 23, 2010
Copyright:  2010 Yamamoto-Hino et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan to SG (No.60280575) and
by the Core Research for Evolutionary Science and Technology (CREST) of Japan Science and Technology Agency (JST). The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: sgoto@a7.keio.jp
¤a Current address: Chemical Resources Laboratory, Tokyo Institute of Technology, Kanagawa, Japan
¤b Current address: Structural Biology Center, National Institute of Genetics, Shizuoka, Japan
¤c Current address: RIKEN Advanced Science Institute (ASI), Japan Science and Technology Agency (JST), ERATO Glycotorilogy Project, Saitama, Japan
Introduction
Neural cells require correct glycosylation patterns for their
development, function, and viability. An example of this is the
attachment of an a1,3-fucose moiety to an N-glycan core via a1,3-
linkage [1], a process which is prevalent in neural cells in Drosophila
[2]. This a1,3-fucose moiety can be detected with an anti-horse
radish peroxidase (HRP) antibody and therefore has also
previously been referred to as an HRP epitope. The a1,3-fucose
is thought to be essential for neural development, function, and
behavior because a nac (neurally altered carbohydrate) Drosophila mutant
that lacks this a1,3-fucose moiety exhibits deformation of the eyes
[3], the misrouting of wing sensory neurons [4], and abnormal
grooming behavior [5]. However, as it remains unclear that the nac
mutation impairs only a1,3-fucosylation, the necessity of a1,3-
fucosylation for neural development and/or function in Drosophila
has not been conclusively demonstrated.
The enzyme a1,3-fucosyltransferase (FucTA) [6], which is
mainly expressed in neural cells, directly catalyzes a1,3-fucosyla-
tion. In addition to FucTA, other glycosylation-related proteins
such as UDP-GlcNAc: a-3-D-mannoside-b -1,2-N-acetylglucosa-
minyltransferase I (Mgat1) [7], GDP-mannose 4,6-dehydratase
(Gmd) [8], and a GDP-fucose transporter (Gfr) [9,10] are required
for a1,3-fucosylation. Whereas Mgat1 provides a preferred
substrate for FucTA by adding N-acetylglucosamine to the
nonreducing end of an N-glycan, Gmd and Gfr are responsible
for the synthesis and transport, respectively, of GDP-fucose,
another substrate for FucTA. These genes, in contrast to the gene
encoding FucTA, are widely expressed in various tissues and also
utilized for other glycosylation processes such as O-fucosylation of
Notch, a1,6-fucosylation of N-glycans, and formation of complex
type N-glycans. Hence, the neural-specific expression of FucTA
appears to account for the neural-specific regulation of a1,3-
fucosylation. However, the mechanisms regulating FucTA expres-
sion have remained largely unknown.
Forward genetic approacheshaveproventobe powerful methods
of elucidating novel mechanisms. For example, the study of
Drosophila genetics has yielded important contributions to our
understanding of the developmental significance of proteoglycans
[11,12] and Fringe-dependent Notch glycosylation [13]. Genetic
screens for mutations affecting morphogenesis and growth factor
signaling have now identified a number of genes involved in Notch
glycosylation and/or proteoglycan formation. Most of these genes
are conserved in mammals, suggesting that Drosophila is a useful
model system for the study of glycosylation in metazoans. However,
although previously performed screens of this nature have identified
glycosyl enzymes and nucleotide sugar transporters, to date they
have not been used to uncover regulators of these molecules.
PLoS Genetics | www.plosgenetics.org 1 December 2010 | Volume 6 | Issue 12 | e1001254To elucidate novel regulatory mechanisms underlying neural-
specific glycosylation, we performed a genetic screen in Drosophila
and identified 109 genes required for glycosylation of a retinal
neural cell-specific protein. These included 95 genes that are
newly implicated in this process and 9 functional groups.
Furthermore, 17 genes were identified to be specifically required
for a1,3-fucosylation. Among these genes, we further analyzed the
function of second mitotic wave missing (Swm), which contains an
RNA-binding motif. Here, we show that Swm directly binds to
fucTA mRNA, upregulates fucTA mRNA and protein levels, and
facilitates the nuclear export of fucTA mRNA in neural cells. These
results indicate that Swm is involved in neural-specific glycosyl-
ation in addition to the cell cycle, in which its involvement has
been previously reported [14]. This report, the first large-scale
screen for glycosylation in a multicellular organism, has thus
identified a number of new genes directly or indirectly involved in
glycosylation and unveiled a novel regulatory mechanism of
neural-specific glycosylation.
Results
Biological significance of a1,3-fucosylation
As a1,3-fucosylation has not proven to be essential for neural
development and/or function in Drosophila, we first aimed to
determine the neural function of a1,3-fucosylation. A phenotype
of a piggyBac insertional mutant for the fucTA gene, fucTA
f03774,
was examined. To validate this mutant, its central nervous system
(CNS) was stained using anti-HRP antibody. The mutant CNS
was negative for anti-HRP staining, suggesting that a1,3-
fucosylation was compromised (data not shown). CNS morphology
was then compared between wild-type and fucTA mutant third
instar larvae. The longitudinal length-to-width ratio of the ventral
nerve cord (VNC) was significantly lower in fucTA mutants than in
wild-type larvae (Figure 1A and 1B), indicating that a1,3-
fucosylation plays an important role in neural development.
However, the staining patterns of antibodies such as 22C10,
BP102, anti-FasI, anti-FasII, and anti-FasIII were not noticeably
different in the fucTA mutant (data not shown).
Screening strategy
To reveal novel regulatory mechanisms underlying neural-
specific glycosylation, a genetic screen was performed in adult
Drosophila using the RNAi-mediated tissue-specific gene knock-
down method. The procedure is summarized in Figure 2A. We
chose eye-specific knockdown because eyes bear the neural-
specific glycan a1,3-fucose. Additionally, the ablation of genes
essential for development and/or cell viability in eyes might not
cause knockdown fly lethality, whereas their ablation in the central
and/or peripheral nervous systems would be lethal. DsRNAs
targeting different genes were expressed in Drosophila eyes by
crossing the eye-specific Gal4 driver, GMR-Gal4, with the
corresponding strains. These strains harbored inverted repeats of
a portion of the corresponding cDNA downstream of the yeast
upstream activating sequence (UAS), which is activated by
the Gal4 protein (http://www.shigen.nig.ac.jp/fly/nigfly/about/
aboutRnai.jsp).
In our screen, the glycosylation of a model eye-specific
glycoprotein was examined, as this allowed us to accurately
measure the number of glycans added. We chose Chaoptin (Chp)
[15] as our model glycoprotein based on the following advantages:
(i) Chp is modified by neural-specific a1,3-fucosylation; (ii) detailed
information is available on both the structures of the N-glycans
and their attachment sites on Chp (described below in detail) [16];
and (iii) simple protein affinity purification is possible using an
anti-Chp antibody (24B10). As shown in Figure 2B, Chp protein
Author Summary
Glycosylation plays crucial regulatory roles in various
biological processes such as development, immunity, and
neural functions. Accordingly, some glycans are generated
in a stage- and tissue-specific manner. To address how
such distinct glycosylation is regulated in different tissues,
we performed a large-scale screen for genes involved in
glycosylation of a neural-specific protein. We identified 109
genes, 95 of which are assigned for the first time as directly
or indirectly involved in glycosylation. We further found
that neural-specific glycosylation is regulated at the RNA
level, which is a novel regulatory mechanism of tissue-
specific glycosylation.
Figure 1. FucTA is required for proper shape of the ventral nerve cord. (A) The wild-type (CS) and fucTA mutant (fucTA
f03774) third instar
larval CNS. (B) The ratio of longitudinal length to width in fucTA mutants was significantly lower that that in wild-type larvae. Results are the mean 6
SD (n=19 CS, n=10 fucTA
f03774 larvae). **p,0.01.
doi:10.1371/journal.pgen.1001254.g001
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Blue (CBB) staining.
Chp is a Drosophila glycoprotein essential for rhabdomere
formation in adult photoreceptor cells, which is mediated through
cell adhesion activity [15,17]. N-glycosylation of Chp was recently
shown to play a pivotal role in its stability, transport to the plasma
membrane, and cell adhesion activity [18]. Chp N-glycan
structures are classified as high-mannose type, pauci-mannose
type, or complex type [16]. Glycan structures added to Chp are
summarized in Figure S1. Interestingly, a1,3-fucose is added only
at N1012, suggesting that Chp has a single difucosylated glycan at
N1012. To detect these glycan structures, the binding of glycan
probes such as lectins and anti-HRP antibody was examined.
Immunopurified Chp was subjected to lectin blot or immunoblot
analysis using ABA, ConA, DBA, DSA, LCA, Lotus, PHA-L4,
PNA, SBA, UEA, and WGA lectins and anti-HRP antibody. The
specificity of these lectins and anti-HRP antibody is summarized in
Table S1. The binding abilities of these probes were quantified
relative to the amount of Chp protein (Figure 2C). These analyses
suggested that the WGA, ConA, LCA, and DSA lectins and anti-
HRP antibody would be useful as glycan probes in our assay
system. As represented in Figure S1, WGA and ConA detect N-
acetylglucosamine (GlcNAc) and mannose moieties of N-glycan
core regions, respectively. LCA preferentially binds to N-glycans
with a1,6-fucose and even weakly recognizes the core regions of N-
glycans. Anti-HRP antibody binds to the a1,3-fucose moieties
attached to the core [1,19]. DSA recognizes GlcNAc at the non-
reducing end of N-glycans.
Chp protein purified from knockdown flies was subjected to
lectin and immuno-dot blot analyses using the same glycan probes
described above and an anti-Chp antibody. An example of the dot
blot analysis is shown in Figure S2. The glycan moieties detected
by these probes were quantified relative to Chp protein, and the z-
scores for each knockdown experiment were thus calculated. For
verification of this procedure, a dsRNA that targets FucTA was
expressed. The resulting knockdown of fucTA decreased the
affinity of Chp to the anti-HRP antibody (66.2611.8% of the
control, Figure 2D). Given the results of our previous mass
spectrometry study showing that a1,3-fucose is added to the Chp
N1012 site [16], Chp was purified from fucTA knockdown eyes,
and mass spectrometry analysis was performed. The glycan
structures attached to N1012 are summarized in Figure S3. The
number of glycans with two fucoses present at N1012 (M3F2Gn2
and M3F2Gn3) selectively decreased in fucTA knockdown eyes
(Figure 2E). This finding is consistent with those of previous studies
reporting that most single- or double-fucosylated N-glycans bear
a1,6-fucose alone, or both a1,6- and a1,3-fucose, respectively, in
embryos [20] and adults [6].
Identification of glycosylation-related genes
A large-scale screen was performed in the current study using an
RNAi library that was previously constructed in National Institute
of Genetics, Japan (NIG, http://www.shigen.nig.ac.jp/fly/nigfly/
about/aboutRnai.jsp). With this library, the expression of 6923
Drosophila genes can be suppressed. From the primary screen
followed by tests for reproducibility, 171 genes were identified as
candidate genes, knockdown of which compromised glycosylation
(Table S2). Since these candidate genes likely included false-
positives due to the off-target effects of RNAi [21], the results were
validated by repeating the knockdown experiments using second-
ary sets of dsRNAs. During the construction of these secondary
sets of dsRNAs, we ensured that the target regions did not overlap.
Of the 171 primary candidate genes, only 80 could be tested
because, in most cases, the induction of the secondary sets of
dsRNA resulted in lethal or severe eye malformation or cDNAs
were too short to permit the design of secondary target regions. Of
the 80 genes tested successfully, 57 were verified to be involved in
glycosylation. Sources of the RNAi strains used for the verification
of the 57 genes are listed in Table S2 (see ‘‘Line ID or
transformant ID used for validation’’). When the validation results
were compared with the calculated off-target probability scores
Figure 2. Screening strategy and validation of the primary
screen for genes whose knockdown impairs glycosylation. (A)
Outline of screen design. (B) Coomassie Brilliant Blue (CBB) staining of
Chp affinity-purified with anti-Chp antibody and separated by SDS-
PAGE. Chp could be purified as a single band (,150 kDa) by a single
step of affinity purification. (C) Binding abilities of glycan probes to
purified Chp. The signal intensities normalized to the amount of Chp
are represented. (D) Anti-HRP antibody reactivity normalized to Chp
levels was decreased in fucTA knockdown flies (fucTA KD) compared to
that in control gfp knockdown flies (gfp KD). Results are the mean 6 SD
of 4 experiments. ***p,0.005. (E) Glycan structures attached to N1012
of Chp revealed by mass spectrometry analysis. Percentages of each
structure in the control (left, gfp KD) and fucTA knockdown conditions
(right, fucTA KD) are listed. The glycans bearing a1,3-fucose are
highlighted (gray). Schematic structures are represented in Figure S3.
M, mannose; F, fucose; Gn, N-acetylglucosamine. ND, not detected.
doi:10.1371/journal.pgen.1001254.g002
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validated genes had scores of less than 3, whereas the scores of
60.7% of the genes yet to be validated were greater than 2. Thus,
the genes with OTPS less than 3 were rescreened by testing
whether knockdown of their suspected off-target genes led to
glycosylation defects. When knockdown of the suspected off-target
genes did not induce any glycosylation defects, the corresponding
genes were classified as glycosylation-related genes (rank 2) along
with the genes that were validated by secondary dsRNAs (rank 1)
(Table S4).
To successfully identify additional glycosylation genes, we
searched for genes that interacted with our newly identified genes
in the yeast two-hybrid database BIOGRID (http://www.
thebiogrid.org/) and in the genetic interaction data listed in
FlyBase (http://flybase.bio.indiana.edu/). The RNAi fly strains
harboring candidate genes that did not already exist in our library
were obtained from the Vienna Drosophila RNAi Library Center
(VDRC) [23] (Table S3). Among the 186 genes tested, 10 genes
showed glycosylation defects. Further validation experiments
identified 1 rank-1 and 5 rank-2 glycosylation-related genes
among them. In total, 109 genes were eventually isolated and
identified as glycosylation-related genes (Table S4). Significantly,
although 14 of the 109 identified genes have already been shown
to be involved in glycosylation, the remaining 95 genes were newly
assigned to this category by our analysis.
Clustering of glycosylation genes
Glycosylation-related genes were classified based on their
domain structures and presumptive functions using the InterPro
(http://www.ebi.ac.uk/interpro/), FlyBase (http://flybase.org/),
and Panther (http://www.pantherdb.org/) databases. The gene
functional groups obtained included glycosylation reactions,
transcription, RNA regulation, translation, intracellular traffick-
ing, cytoskeletal regulation, signal transduction, protein degrada-
tion, mitochondrial function, and other functions (Figure 3A,
Table S4).
Genes regulating neural-specific glycosylation
To identify genes specifically involved in neural-specific
glycosylation, we selected genes whose knockdown induced only
abnormal anti-HRP binding activity from among the 109 genes
listed in Table S4. From this analysis, 17 genes showing a1,3-
fucosylation-specific defects were identified belonging to seven
functional groups (Figure 3B). In the RNA regulation group, swm
(CG10084) [14], Pabp2 (CG2163) [24], and Hel25E (CG7269) are
suggested to interact with each other in the Drosophila interaction
database STRING (http://string.embl.de/) and literature [25].
Swm and Pabp2 are required for a1,3-fucosylation
Since Swm and Pabp2 have been reported to physically interact
with each other in BIOGRID, the roles of these genes were further
analyzed in the context of glycosylation. To analyze the
glycosylation defects induced by the knockdown of these genes
in further detail, Chp glycans in the swm and Pabp2 knockdown
lines were subjected to mass spectrometric analysis. The ratio of
the a1,3-fucosylated form (M3F2Gn2) at N1012 was markedly
decreased in both knockdown lines, whereas the other form
(M3F2Gn3) was only slightly affected by swm or Pabp2 knockdown
(Figure 4A). These results suggest that Swm and Pabp2 are
required for a1,3-fucosylation and that the M3F2Gn2 form might
be more sensitive than the M3F2Gn3 form to decreases in Swm
and Pabp2.
Since swm and Pabp2 mutants have been previously isolated [26]
(Flybase), glycosylation defects were also examined in the
amorphic and hypomorphic alleles of swm, swm
F14 and swm
F15,
respectively, and the hypomorphic allele of Pabp2, Pabp2
KG02359.
All cells homozygous for swm mutations were generated in whole
Drosophila eyes using a modified FLP/FRT system [27]. Chp was
isolated from these mutant eyes and detected by immunoblotting
with anti-Chp and anti-HRP antibodies to quantify the amount of
a1,3-fucose added to Chp. The a1,3-fucose added in swm
F14,
swm
F15, and Pabp2
KG02359 cells decreased to 22.7% 6 4.8%, 28.3%
6 7.3%, and 59.5% 6 8.8% of wild-type levels, respectively
(Figure 4B). These results are further evidence from knockdown
experiments that Swm and Pabp2 are somehow required for a1,3-
fucosylation.
Although Pabp2 is known to participate in polyA addition, the
function of Swm is largely unknown. Thus, we focused on the role
of Swm in glycosylation. Modification of a1,3-fucose is widely
utilized for Drosophila neural proteins. Thus, we first examined
whether swm depletion affects not only Chp but also a wide range
of other proteins. Homogenates of adult eyes heterozygous or
homozygous for swm
F14 and swm
F15 were analyzed by immunoblot
analysis with an anti-HRP antibody (Figure 5A). Several positive
bands were detected, including a high-molecular-weight band
corresponding to Chp (,150 kDa). Quantitative comparison
between heterozygotes and homozygotes of the same swm alleles
revealed that anti-HRP antibody affinity was reduced in most
bands in the homozygotes, with the exception of an approximately
30-kDa product (Figure 5A and 5B). The decrease was much
larger in swm
F14 than in swm
F15 mutants, consistent with the
severity of these mutations. Taken together, our data indicate that
Swm is required for the a1,3-fucosylation of most proteins that are
usually modified by a1,3-fucose.
Figure 3. Screening results. (A) Functional classification of the 109
glycosylation-related genes. (B) Functional classification of the 17 a1,3-
fucosylation-specific glycosylation-related genes. The number of genes
in each category is listed.
doi:10.1371/journal.pgen.1001254.g003
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was also supported by the immunostaining of eyes with anti-HRP
antibody. Adult photoreceptor cells from swm knockdown and
control flies were simultaneously stained with anti-HRP and anti-
Chp antibodies (Figure 5C). Control photoreceptor cells appeared
yellow in color because the intensities of green signal (anti-HRP)
and red signal (anti-Chp) were nearly equal in this condition. In
contrast, swm knockdown cells appeared relatively red in color,
suggesting that the intensity of green signal was reduced compared
to the red signal. These data clearly indicate that the signal
strength of anti-HRP relative to anti-Chp was reduced in the
knockdown photoreceptor cells compared to control cells.
Since a1,3-fucosylation is directly catalyzed by FucTA, the
Swm-dependence of FucTA protein expression was examined.
Because no anti-FucTA antibody was available, a knock-in fly was
generated in which the fucTA locus was replaced by a Myc-tagged
fucTA gene (Figure S4A and S4B). When swm dsRNA was
expressed by GMR-Gal4, FucTA-Myc protein levels were reduced
to 47.562.4% of control values as revealed by immunoblot
analysis (n=2) (Figure 6A and Figure S4C). The reduction of
FucTA-Myc levels in swm mutant tissue was also examined. We
costained the CNS of first instar larvae with anti-Myc and anti-
GM130, a Golgi marker. The number of Golgi harboring FucTA-
Myc protein was markedly decreased in swm
F14 mutants (2.0% of
total Golgi) compared to wild-type larvae (43.1% of total Golgi,
Figure 6B). The different ratios of FucTA-Myc reduction observed
in the biochemical and immunostaining experiments may be due
to different levels of Swm depletion in knockdown and mutant
flies.
Functional analyses of Swm
Although Swm has an RNA recognition motif (RNP-1) that is
present in a wide variety of other RNA binding proteins [26], it
remained undetermined whether Swm directly bound to mRNA.
Figure 5. Immunoblot analysis. (A) Immunoblot analysis of whole-
eye extracts from swm
F14 and swm
F15 mutants (swm
F14 and swm
F15). The
anti-HRP antibody detected several bands, including Chp (Band 1). Anti-
HRP antibody reactivity was decreased in swm mutant homozygotes
(2/2) compared with heterozygotes (+/2). Loading controls with anti-
Chp and a-tubulin antibodies are shown. (B) Quantified immunoblot
band intensity. HRP-positive band intensities were normalized to the
intensities of corresponding anti-a-tubulin signals. The values normal-
ized to those in swm
F15 heterozygotes (+/2) are represented. (C) Anti-
HRP signal (green) relative to anti-Chp signal (red) in swm knockdown
mutants (GMR . swm
RNAi) was obviously reduced compared to that in
control knockdown mutants (GMR . gfp
RNAi). Scale bar: 100 mm.
doi:10.1371/journal.pgen.1001254.g005
Figure 4. Swm and Pabp2 are required for neural-specific a1,3-
fucosylation. (A) Glycan structures attached to N1012 of Chp as
revealed by mass spectrometry analysis. The percentages of each
structure in the control (left, gfp KD), swm (middle, swm KD), or Pabp2
(right, Pabp2 KD) knockdown condition are listed. The glycans bearing
a1,3-fucose are highlighted (gray). ND, not detected. (B) a1,3-
fucosylation in swm and Pabp2 mutants. Anti-HRP antibody reactivity
normalized to Chp levels was markedly decreased in swm
F14, swm
F15,
and Pabp2
KG02359 mutants. Results are the mean 6 SD of 3 experiments.
***p,0.005.
doi:10.1371/journal.pgen.1001254.g004
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Flag-tagged Swm in the Drosophila neural cell line BG2-c6 [28] and
by performing immunoprecipitation with an anti-Flag antibody.
The quantity of endogenous fucTA mRNA that coprecipitated with
Swm-Flag was higher in Swm-Flag–expressing cells than in
controls in which Swm-Flag was not expressed or immunoprecip-
itation was performed using a control IgG (Figure 6C). These
results strongly suggest that Swm binds to fucTA mRNA in vivo.
The amount of fucTA mRNA under the control of Swm was
next examined. dsRNA targeting swm was introduced into BG2-c6
cells, and the amount of endogenous fucTA mRNA was measured.
In addition to a decrease in swm mRNA, to 27.3 6 1.9% of the
control level (n=3), the amount of fucTA mRNA also decreased to
60.6 6 10.5% of the control level (Figure 6D). Furthermore, the
stability of fucTA mRNA was examined in swm knockdown cells.
The amount of fucTA mRNA was measured at 30, 60, and 90 min
Figure 6. Swm regulation of expression and nuclear export of fucTA mRNA. (A) Quantification of FucTA-Myc in control (gfp KD) and swm
(swm KD) knockdown eyes. In this figure, all results shown in graphs are the mean 6 SD, n=2. (B) Expression of FucTA-Myc in the Golgi complex was
reduced in swm
F14 mutants. FucTA-Myc (green) was well colocalized to the Golgi detected by anti-GM130 (red) in control eyes (arrows, +;fucTA-Myc
KI).
In contrast, FucTA-Myc was hardly colocalized to the Golgi (arrowheads) in swm mutants (swm
F14; fucTA-Myc
KI). Scale bar: 10 mm. (C) In vivo binding of
Swm and endogenous fucTA mRNA. Endogenous fucTA mRNA was immunoprecipitated with an anti-Flag antibody (M2) from BG2-c6 cells expressing
Swm-Flag and detected by RT-PCR (bottom). Control experiments were performed without Swm-Flag expression (2) or by immunoprecipitation with
a mouse IgG antibody (mIgG). (D) Decrease of fucTA mRNA in swm knockdown BG2-c6 cells. Levels of fucTA RNA in swm knockdown cells was
normalized to that in control gfp knockdown cells, n=3. ***p,0.005. (E) Decay of fucTA mRNA in swm knockdown BG2-c6 cells. Levels of fucTA mRNA
at each time point after actinomycin D addition were normalized to those at time 0, n=3. (F) Ratios of fucTA and actin (act5c) mRNA levels in nuclear
vs. cytoplasmic fractions in swm knockdown BG2-c6 cells were normalized to those in control gfp knockdown cells. n=4. (G) PolyA length of fucTA
mRNA in swm knockdown BG2-c6 cells. PolyA of fucTA was amplified by PCR and detected by Southern blotting with a probe corresponding to fucTA.
doi:10.1371/journal.pgen.1001254.g006
Large-Scale Screen for Glycosylation-Related Genes
PLoS Genetics | www.plosgenetics.org 6 December 2010 | Volume 6 | Issue 12 | e1001254after total transcription was inhibited by addition of actinomycin D.
Decay rates of fucTA were indistinguishable between swm knock-
down and control cells (swm, t1/2=97.72; control, t1/2=100.48,
Figure 6E). These data suggest that Swm is involved in the
expression of fucTA mRNA but not in its stability.
Swm was recently reported to incorporate into the complex that
regulates nuclear export of mRNAs [29]. The necessity of Swm for
the nuclear export of fucTA mRNA was therefore examined in
BG2-c6 cells. Following separation of cell lysates into nuclear and
cytoplasmic fractions, fucTA mRNA levels were measured in each
fraction of swm knockdown and control cells. The amount of fucTA
mRNA in the nucleus increased by 9.6-fold in swm knockdown
cells compared to control gfp knockdown cells (Figure 6F). The
nuclear export of actin (act5c) mRNA was also examined in swm
knockdown cells. The amount of actin mRNA in the nucleus
increased by 1.7-fold in swm knockdown cells compared to control
cells. However, the fold change in nuclear accumulation of actin
mRNA was significantly lower than that of fucTA mRNA in swm
knockdown cells (Figure 6F). These results suggest that relatively
more Swm is required for nuclear export of fucTA mRNA than for
nuclear export of actin mRNA.
Since nuclear export defects have been reported to result in an
abnormally longer polyA length of mRNAs [29], the polyA length
of fucTA mRNA was examined in swm knockdown cells. The polyA
length of fucTA mRNA was clearly longer in swm knockdown cells
than in control cells (Figure 6G). Collectively, these results indicate
that Swm positively regulates a1,3-fucosylation by promoting
nuclear export of fucTA mRNA in neural cells.
Discussion
The current literature on glycosylation regulatory mechanisms
is remarkably limited, and our current study is in fact the first
report of a large-scale screen for glycosylation genes using a
multicellular organism. We identified 109 genes in our screen,
including 95 genes that have not been previously associated with
glycosylation. In silico analyses using the available Drosophila
databases suggested that these gene products participate in a
variety of cellular processes (Figure 3), among which RNA
regulation is, for the first time, shown to play an important role
in the context of glycosylation. Moreover, the candidate genes
belonging to the RNA regulation group were enriched by
rescreening for a1,3-fucosylation-specific genes.
Biological significance of a1,3-fucosylation
In the current study, the fucTA mutant showed an imbalanced
VNC. The VNC longitudinal length-to-width ratio was signifi-
cantly shorter in fucTA mutants compared to wild-type larvae. To
our knowledge, this is the first report of such shortened VNC in
the loss-of-function mutant, although elongated VNC has already
been reported in mutants for integrin [30], collagen IV [31], DHR3
[32], worniu [33] and C1GalTA [34]. Interestingly, C1GalTA
encodes a core 1 galactosyltransferase that adds galactose to O-
GalNAc attached to Ser or Thr protein residues. Taken together
with our results, glycosylation patterns might affect the VNC
shape. Although how a1,3-fucose affects VNC formation remains
to be revealed, we think that two possible defects may result in a
shortened VNC in fucTA mutants. (1) The aberrantly elongated
VNC in the C1GalTA mutant is proposed to result from
deglycosylation of laminin, a component of the extracellular
matrix. In addition, overexpression of FucTA has recently been
reported to enhance cell migration in the embryonic nervous
system [35]. By analogy with the case of C1GalTA, cell migration
in the larval VNC may be impaired in fucTA mutants because of
aberrant interactions between migrating cells and extracellular
matrix. (2) Another possibility is that neural activity may be
impaired in fucTA mutants because neural activity has been
reported to be necessary for VNC condensation in embryos [31].
This possible defect is consistent with the finding that one of the
major a1,3-fucosylated proteins is a b-subunit of Na
+/K
+ ATPase
essential for the maintenance of neural cell membrane potentials
[36]. It will be interesting to examine whether neural activity is
controlled by glycosylation in the future.
Insight into the genes identified in this screen
Three types of genes were identified in this screen: (1) genes that
specifically regulate glycosylation such as glycosyltransferases,
(2) genes with multiple functions including regulation of expression,
activity and/or localization of glycosyltransferases, and (3) genes
with primary functions other than glycosylation that secondarily
affect glycosylation. For example, knockdown of cytoskeletal
regulation and mitochondrial function genes may secondarily affect
glycosylation as a result of damage to cell structures and viability.
For several reasons, swm might be the second type of gene.
Although swm has been previously reported to show involvement
in the cell cycle [14], no glycosylation defects were observed with
the knockdown of other known cell cycle regulators such as cdc2
(CG5363) or cdk4 (CG5072) (Table S2 and S3). In addition, no cell
cycle defects could be detected in the fucTA mutant. These data
suggest that cell cycle and glycosylation are regulated indepen-
dently. Therefore, swm would play at least two independent roles
in cell cycle and glycosylation.
Traffic genes identified in this screen may be another example
of the second type of genes. The conserved oligomeric Golgi
(COG) complex has been reported to participate in the Golgi
localization of glycosyltransferases and membrane traffic [37], but
no involvement of the COG complex in glycosylation has been
reported in Drosophila. Our screen identified Cog3 as a gene whose
knockdown impaired a1,3-fucosylation. Thus, localization of
FucTA protein was examined in cog3 knockdown photoreceptor
cells. Expressed FucTA was hardly localized to the Golgi complex
in knockdown photoreceptor cells (data not shown). Moreover,
Golgi localization of FucTA was also preliminarily found
compromised by knockdown of vps2 and vps20, other traffic genes
(data not shown). These data raise the possibility that some traffic
genes may be involved in glycosylation by localizing glycosyl-
transferases to appropriate Golgi and/or endoplasmic reticulum
sites.
Preferential requirement of Swm in glycoforms
Our detailed analysis of glycan structures using mass spectrom-
etry revealed that one (M3F2Gn2) of the two forms bearing an
a1,3-fucose (M3F2Gn3 and M3F2Gn2) is more sensitive to the
decrease of swm and Pabp2 than the other (M3F2Gn3). Two
reasons may account for this difference, which are not mutually
exclusive. (1) FucTA productivity differs between these two
glycoforms. The structural difference between the glycoforms
consists of a GlcNAc moiety attached to the nonreducing end of N-
glycans. Given that this GlcNAc moiety has been shown to
increase the reactivity of FucTA to the core of N-glycans [6], we
assume that M3FGn3 is preferentially modified by FucTA to form
M3F2Gn3. Therefore, under the condition of reduction, not
complete loss, of FucTA by swm and Pabp2 knockdown, M3F2Gn2
might be preferentially lost. (2) The other possibility is that Swm or
Pabp2 regulate Mgat1 or Fused lobes (Fdl) [38], the enzymes that
add and remove the GlcNAc moiety, respectively, from the
nonreducing end. In fact, the amount of mRNA encoding Mgat1,
but not fdl, was slightly but significantly increased in swm
Large-Scale Screen for Glycosylation-Related Genes
PLoS Genetics | www.plosgenetics.org 7 December 2010 | Volume 6 | Issue 12 | e1001254knockdown cells (Figure S5). This finding is consistent with the
selective decrease of M3F2Gn2 induced by swm knockdown.
However, it remains undetermined whether the preferential
decrease of glycoforms is caused by an increase in Mgat1, the
preferential productivity of FucTA, or both.
Regulation of fucTA mRNA by Swm
Expression of mRNA is generally regulated at transcription,
splicing, 59-o r3 9-end processing, and nuclear export, and by the
stability of the mRNA. The stability of fucTA mRNA was not
affected by swm knockdown (Figure 6E). Given that 59-end
processing is essential for mRNA stability, the 59-end processing of
fucTA mRNA is not regulated by Swm. In addition, splicing of
fucTA mRNA does not appear to depend on Swm activity since the
misspliced form of fucTA mRNA in the swm knockdown cells could
not be detected when we amplified fucTA mRNA using PCR
primers that targeted different exons (data not shown). Further-
more, both transcription and nuclear export of mRNAs are
regulated by the THO/TREX complex [39] and Sus1 [40]; thus,
Swm may be a factor participating in both processes, with its
depletion resulting in reduced expression and defective nuclear
export of fucTA mRNA. We assume that abnormal extension of
polyA in swm knockdown cells would be a secondary effect of
nuclear export defects, as observed in mutants of genes required
for nuclear export [29]. Moreover, Pabp2, Hel25E/UAP56 [41],
and Nup358 [42], which participate in the nuclear export of
mRNA, were also identified in our screen (Table S4), suggesting
that nuclear export might be essential for glycosylation regulation.
Nuclear accumulation of polyA(+) RNA in swm knockdown S2
cells was confirmed in our in situ hybridization experiment, as
previously reported [43]. However, in neural BG2-c6 cells, weak
polyA(+) RNA signals in nuclei were comparable between control
gfp knockdown and swm knockdown cells (data not shown),
suggesting that only a small portion of mRNA might be exported
by Swm. In addition, the ratio of nuclear to cytoplasmic fucTA
mRNA was relatively higher than that of actin mRNA in swm
knockdown BG2-c6 cells (Figure 6F). Collectively, Swm may have
preferred mRNAs for nuclear export. Moreover, the export
efficiency and/or target RNA preference of Swm may differ
between S2 and BG2-c6 cells.
Mammalian homologs of genes identified in this screen
Most of the genes identified in our present study have
mammalian homologs (Table S5). Among these, Cog3 has been
reported to be involved in glycosylation in organisms ranging from
yeast to humans [37]. Interestingly, mutations of some COG
components are causative for human diseases including congenital
disorders of glycosylation (CDG) [44]. Further investigation of the
genes identified here will likely provide additional insights into
novel glycosylation regulatory mechanisms conserved in organisms
ranging from Drosophila to humans and, possibly, into diseases
involving glycosylation pathways.
Materials and Methods
Fly stocks and clone analysis
The following fly strains were used: Canton-S as the wild-type
strain, GMR-Gal4 (Bloomington Drosophila Stock Center (BDSC)),
fucTA mutant Pbac{WH}FucTAf03774 (BDSC), swm mutants swm
F14
and swm
F15(BDSC), and Pabp2 mutant P{SUPor-P}Pabp2{KG02359}
(BDSC). RNAi lines were mainly supplied by the National Institute
of Genetics (Japan), with the remainder purchased from the Vienna
Drosophila RNAi Center (VDRC). The transgenic flies harboring
UAS-dicer2 were also purchased from VDRC.
Theswmand Pabp2mutantmosaic clonesweregenerated usingthe
FLP-FRT system [27]. Adult heads from a cross of w[*]; P{w[+t*]
ry[+t*]=white-un1}30C swm[F14] P{ry[+t7.2]=neoFRT}40A/CyO,
P{Wee-P.ph0}2o rw [ * ] ;P { w [ +t*] ry[+t*]=white-un1}30C swm[F15]
P{ry[+t7.2]=neoFRT}40A/CyO, P{Wee-P.ph0}2 with y[1]w[*];
P{w[+mC]=GMR-hid}G1 P{ry[+t7.2]=neoFRT}40A, l(2)CL-L[1]/CyO;
P{w[+m*]=GAL4-ey.H}SS5, P{w[+mC]=UAS-FLP1.D}JD2 (BDSC),
or y[1]; P{y[+mDint2] w[BR.E.BR]=SUPor-P}Pabp2[KG02359]
P{neoFRT}42D/SM1 with y[1], w[*]; P{ry[+t7.2]=neoFRT}42D
P{y[+t7.7] ry[+t7.2]=Car20y}44B, P{w[+mC]=GMR-hid}SS2,
l(2)CL-R[1]/CyO; and P{w[+m*]=GAL4-ey.H}SS5, P{w[+mC]=UAS-
FLP1.D}JD2 (BDSC)were dissected and used for glycosylation
analyses as described below.
To investigate the localization of FucTA in RNAi-mutant flies,
inducible Myc-tagged FucTA-expressing flies (UAS-fucTA-Myc)
were generated. fucTA cDNA was a gift from S. Nishihara. A DNA
fragment encoding the 3Myc sequence was ligated to the 39end of
the coding region of fucTA and inserted into the pUAST vector.
The vector was injected into w
1118 embryos for the production of
transgenic flies.
To generate fucTA-Myc knock-in flies (fucTA-Myc
KI), the
procedure was adopted from the ends-out knock in method [45].
Details are shown in Figure S4.
Antibodies and lectins
Commercial sources provided biotin-conjugated Lotus; HRP-
conjugated ConA, WGA, DSA, LCA, UEA, PHAL4, PNA, SBA,
and DBA lectins (Seikagaku Kogyo); and HRP-conjugated ABA
(Sigma). Anti-HRP antibody was obtained from Jackson Immu-
noresearch. In addition, the antibodies used in this study are as
follows: streptavidin-POD (Roche); anti-Myc A14 and anti-Myc
9E10 (Santa Cruz); anti-Flag M2 (Sigma); HRP-conjugated anti-
mouse IgG, HRP-conjugated anti-rabbit IgG, and normal mouse
IgG (Jackson Immunoresearch); Alexa 488-conjugated anti-mouse
IgG, Alexa 488-conjugated anti-rabbit IgG, and TOPRO3
(Invitrogen); and Cy3-conjugated anti-mouse IgG and Cy3-
conjugated anti-rabbit IgG (Kirkegaard & Perry Laboratories,
Inc.). Anti-Chp 24B10, anti-a-tubulin, 22C10, BP102, anti-FasI,
anti-FasII, and anti-FasIII were obtained from the Developmental
Studies Hybridoma Bank. Anti-Chp antibody N8A [18] and anti-
GM130 [46] were generated as described previously.
Primers
The primer sets used for the generation of transgenic flies are
listed in Table S6. The primer sets used for analysis in cultured
cells are listed in Table S7.
Quantification of ventral nerve cord shape
The central nervous systems were manually isolated from CS
and fucTA
f03774 third instar larvae and fixed in 4% paraformal-
dehyde/PBS at 4uC overnight. After several washes with PBS,
brain hemispheres were manually removed and placed flatly onto
slide glasses. The images were captured using an AxioCam-
equipped Zeiss AxioImager M1, and the length and width of
VNCs were measured using AxioVision Rel. 4.7 software.
First screen
The first screen was carried out using a collection of transgenic
fly lines carrying inducible dsRNA constructs. To drive expression
of dsRNA for each gene in the eye, males from each RNAi fly line
were crossed with GMR-Gal4 virgin females. Mating to inducible
RNAi males and egg laying were carried out at 25uC for two days,
and the resulting embryos were then incubated at 28uC. After 2
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for an additional 14 days at 28uC to enhance the effects of
dsRNAs. More than 100 heads per line were isolated and
homogenized in lysis buffer consisting of 10 mM sodium
phosphate (pH 7.0), 100 mM NaCl, 0.5% Triton X-100, and
complete protease inhibitor (Roche). The lysate was incubated
with anti-Chp (24B10) covalently coupled with protein G-
Sepharose (GE Healthcare) for 2 h. The Chp-bound Sepharose
was subsequently washed with lysis buffer, and Chp was eluted
with 50 mM triethylamine-acetic acid (pH 3.5).
Purified Chp was spotted onto Hybond ECL nitrocellulose
membranes (GE Healthcare) using a Bio Dot slot format (Bio-
Rad). After the membrane was blocked with 2% bovine serum
albumin, immuno- or lectin blot analysis was performed with anti-
Chp (N8A), anti-HRP, or HRP-conjugated ConA, LCA, DSA,
and WGA. HRP-conjugated anti-mouse or HRP-conjugated anti-
rabbit IgG was used as the secondary antibody. Detection was
performed using Supersignal West Pico Chemiluminescent
Substrate (Thermo), and quantification performed using a LAS-
1000 Luminescent Image Analysis System (FujiFilm). An example
of the dot blot is shown in Figure S2. Lectin affinity values per Chp
values were converted to log values for normalization. On the basis
of standard deviations from the values of GMR.GFP
RNAi (as a
control), genes with a z-score .3 were considered primary
candidates. In the primary screen, we performed a single assay
round. For the primary candidates, the lectin analysis was
repeated (n=3). Two-sided Student’s t-tests were applied to the
reproducibility test data between lectin values of knockdown and
control flies. Genes with p,0.005 were considered to be
reproducible findings.
Validation
Collection of the second transgenic fly stock lines was designed
in such a way that there was no overlap between the primary
construct in the original library and the new dsRNA sequence, and
that the new dsRNA sequence had a low off-target probability
score calculated by dsCheck [22]. Using the second lines, lectin
analysis was independently repeated (n=2), and the values
between the knockdown and control (GMR.GFP
RNAi) were tested
by two-sided Student’s t-tests. Genes with p,0.05 were considered
glycosylation-related genes (Rank 1). When no change in lectin
values was observed solely using GMR-Gal4, the examination was
repeated using GMR-Gal4; UAS-dicer2 (VDRC). RNAi flies from
VDRC whose target sequence had no overlap with the primary
construct were also used as second lines.
For candidate genes that were not evaluated with the second
lines, first the number of 19mers with a perfect match to each
Drosophila transcript was calculated using dsCheck. The highest
number of 19mers with a perfect match to the off-target gene was
defined as the ‘‘off-target probability score’’. The genes with a
score below 3 were tested to determine whether knockdown of
their suspected off-target genes led to glycosylation defects. When
the knockdown of the suspected off-target genes did not lead to
any evidence of glycosylation defects, the corresponding genes
were added to the list of genes required for glycosylation (Rank 2).
GO analysis
Our final glycosylation hit list was annotated to include
information on protein domain, molecular function, and protein
family by cross-referencing InterPro (version 20.0 and 21.0) [47],
Flybase, and Panther [48]. On the basis of the resulting
annotation, genes were manually classified into 9 categories.
These annotations are shown in Table S4.
Mass spectrometry (MS) analysis of glycopeptides and
glycan structure
MS analysis of glycopeptides was performed as previously described
[16]. Purified Chp was digested with modified trypsin (Promega).
Glycopeptides and peptide mixtures were separated by reversed-phase
high-performance liquid chromatography (RP-HPLC) using an
Inertsil C18 column (GL Science). The matrices for peptide analysis
by matrix-assisted laser desorption/ionization time-of-flight MS
(MALDI-TOF-MS) spectra were acquired using a Voyager mass
spectrometer (Applied Biosystems). MS/MS measurements were
performed using an Ultraflex TOF/TOF mass spectrometer with the
LIFT-MS/MS facility (Bruker Daltonics GmbH).
Immunostaining
To investigate the amount of a1,3-fucosylation in vivo, frozen
sections of adult eye demonstrating swm or gfp knockdown were
prepared. Immunostaining was performed as previously described
[49]. Fluorescent images were acquired with a laser scanning
confocal microscope, LSM700 (Zeiss).
Cell culture, plasmid construction, transfection, and
siRNA treatment
BG2-c6 cells were cultured in M3 medium (Sigma) containing
10% FBS and 10 mg/mL insulin (Invitrogen) at 25uC. Transfec-
tion was performed using a calcium phosphate transfection kit
(Invitrogen).
To construct an expression plasmid for C-terminal Flag-tagged
Swm (Swm-Flag), cDNA containing the swm coding region was
obtained from Canton-S total RNA by RT-PCR. A DNA fragment
encoding the 3Flag sequence was ligated to the 39end of the swm
coding region and inserted into the expression vector pRmHa.
For the transient expression of Swm-Flag, 1.5 mg plasmid was
added to each well of a 24-well plate, in which 5610
5 BG2-c6 cells
had been seeded. Plasmid expression was induced by incubating
cells in the presence of 0.1–0.5 mM CuSO4 for periods from 3 h
to overnight.
For knockdown experiments, dsRNA for swm or gfp was
produced using in vitro transcription T7 kit (Takara). A 3-mg
aliquot of dsRNA was added to each well of a 24-well plate in
which 5610
5 cells had been seeded. After 5 days, cells were
harvested for the following assays.
Immunoblot
For protein analysis, equal amounts of protein extracted from
fly eyes were subjected to SDS-PAGE. After transfer to PVDF
membranes (Millipore), membranes were blocked in PBS
containing 0.05% Tween 20 and 5% skim milk and incubated
overnight with the primary antibody, followed by the secondary
antibody. A monoclonal anti-a-tubulin antibody was used for
normalization. Detection was performed using the Supersignal
West Pico Chemiluminescent Substrate.
RNP-IP assay
Immunoprecipitation of protein–RNA complexes was per-
formed according to a protocol by Niranjanakumari et al. [50].
BG2-c6 cells transfected with swm-Flag were harvested and cross-
linked in PBS containing 0.2% PFA. Following sonication in RIPA
buffer (50 mM Tris-HCl pH 7.5, 1% NP-40, 0.05% SDS, 1 mM
EDTA, 150 mM NaCl) with protease inhibitor (Nakarai), each
supernatant was mixed with a monoclonal anti-Flag M2 antibody
or normal mouse IgG and then incubated with protein-G beads
(GE Healthcare) at 4uC for 6 h. Sepharose beads were washed 5
times with RIPA buffer and incubated in 50 mM Tris (pH 7.0),
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reverse cross-linking. RNA was extracted from the immunopre-
cipitates using Sepasol reagent (Nakarai) followed by DNase I
treatment. The extracted RNA was used as a template to
synthesize cDNA using Superscript III (Invitrogen) according to
the manufacturer’s protocol.
Real-time PCR
Total RNA was extracted using the RNeasy mini kit (Qiagen) or
Sepasol reagent (Nakarai). Complementary DNAs were synthe-
sized using Superscript III according to the manufacturer’s
protocol. Real-time PCR was carried out using a 7900HT Fast
Real Time PCR system (Applied Biosystems) with Power Syber
Green. Samples were normalized with Drosophila rpl32.
RNA degradation analysis
BG2-c6 cells transfected with gfp or swm dsRNA were grown for
5 days, and then actinomycin D (Nakarai) was added to a final
concentration of 5 mg/mL to arrest de novo RNA synthesis. At 30,
60, and 90 min after actinomycin D treatment, the cells were
harvested, and fucTA and rpl32 (control) mRNA was quantified by
real-time PCR as described above.
PAT assay
PolyA measurement of fucTA mRNA was carried out as
described [51]. PCR fragments from the PAT assay were
separated on 2% agarose gels and visualized by Southern blot
using DIG DNA Labeling and Detection kit (Roche).
Subcellular fractionation
Fractionation and RNA isolation were performed as described
[52]. The cytoplasmic fraction was extracted by hypotonic buffer
(10 mM Tris (pH 7.5), 10 mM NaCl, 3 mM MgCl2, 0.5% (v/v)
Nonident P-40, 40 units/mL RNase inhibitor, 1 mM DTT) and
then extracted by EDTA buffer (10 mM Tris (pH 7.5), 10 mM
NaCl, 40 mM EDTA, 0.5% (v/v) Nonident P-40, 40 units/mL
RNase inhibitor, 1 mM DTT). The remaining pellet was used as
the nuclear fraction. Sepasol solution was used to purify mRNA
from each fraction as described above.
Human homologs
The InParanoid database (version 7.0) was searched for
mammalian homologs [53].
Supporting Information
Figure S1 Schemes of Chp glycan attachment sites and glycan
structures. (upper) The glycosylated sites in Chp are indicated as
‘Y’ with amino acid positions. The colors represent the glycan
types. Open boxes in Chp protein indicate leucine-rich repeats.
(lower) Schemes for three types of glycan structures are
represented. The number of sugars is indicated in parentheses
following the sugar name. The moieties recognized by lectins are
encircled by lines colored to indicate the lectin species.
Found at: doi:10.1371/journal.pgen.1001254.s001 (9.83 MB TIF)
Figure S2 An example of dot blot analysis for the screen. Chp
purified from adult heads with the knockdown of each gene
(1A,11H) and the control gfp (12A,12H) was blotted and
detected with anti-Chp (left) and anti-HRP (right). The control
Chp was sequentially diluted and blotted at the points from 12A to
12H. Dots in red squares represent anti-Chp and anti-HRP signals
against Chp purified from swm knockdown flies.
Found at: doi:10.1371/journal.pgen.1001254.s002 (4.28 MB TIF)
Figure S3 Glycan structures attached to N1012 in Chp. Six
glycan structures that were identified by mass spectrometry
analysis are schematically represented.
Found at: doi:10.1371/journal.pgen.1001254.s003 (5.23 MB TIF)
Figure S4 Knock-inof the fucTA gene by ends-out recombination.
(A) The donor DNA was generated by FLP and I-SceI action from
the X chromosome (top). Homologous recombination was used to
insert the 3Myc sequence into the endogenous fucTA gene and the
white gene into the region between fucTA and Msh6 genes (middle).
Theexpectedstructure(bottom)wasverifiedbyPCRwithtwosetsof
primers (colored thick arrows). (B) Expected bands were amplified
with two sets of primers (red, fucTA locus; blue, Msh6 locus) using
chromosomal DNA from a fucTA knock-in fly (fucTA-Myc
KI)b u tn o t
in white flies (w). (C) Myc-tagged FucTA protein (arrow) was detected
by immunoblot using anti-Myc antibody in the adult eye extracts of
fucTA knock-in flies (fucTA-Myc
KI) but not in white flies (w). The
amount of Myc-tagged FucTA protein was reduced in swm
knockdown eyes (swm KD) compared to the control eyes (gfp KD).
Found at: doi:10.1371/journal.pgen.1001254.s004 (8.80 MB TIF)
Figure S5 The amount of Mgat1 and fdl mRNA in swm
knockdown BG2-c6 cells. The amount of mRNA encoding Mgat1
was slightly but significantly increased, whereas that of fdl mRNA
was not changed in swm knockdown cells compared with control
gfp knockdown cells, n =3 .* p , 0.05.
Found at: doi:10.1371/journal.pgen.1001254.s005 (1.77 MB TIF)
Table S1 Specificity of the lectins used in this study.
Found at: doi:10.1371/journal.pgen.1001254.s006 (0.02 MB
XLS)
Table S2 Glycosylation Screening Results using NIG RNAi fly
strains.
Found at: doi:10.1371/journal.pgen.1001254.s007 (1.39 MB
XLS)
Table S3 Glycosylation Screening Results using VDRC RNAi
fly strains.
Found at: doi:10.1371/journal.pgen.1001254.s008 (0.06 MB
XLS)
Table S4 Glycosylation-related genes identified in this study.
Found at: doi:10.1371/journal.pgen.1001254.s009 (0.08 MB
XLS)
Table S5 Manmalian homolog.
Found at: doi:10.1371/journal.pgen.1001254.s010 (0.03 MB
XLS)
Table S6 Primer Sequences for transgenic fly.
Found at: doi:10.1371/journal.pgen.1001254.s011 (0.03 MB
XLS)
Table S7 Primer Sequences used in this study in cultured cells.
Found at: doi:10.1371/journal.pgen.1001254.s012 (0.02 MB
XLS)
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